High-dose omega-3s as an add-on therapy to statins for preventing coronary artery calcium progression Original paper

In this randomized controlled trial, adding high-dose omega-3 fatty acids to statin therapy did not affect coronary artery calcium score, compared to statin therapy alone.

This Study Summary was published on March 22, 2024.

Quick Summary

In this randomized controlled trial, adding high-dose omega-3 fatty acids to statin therapy did not affect coronary artery calcium score, compared to statin therapy alone.

What was studied?

The effect of high-dose omega-3 fatty acids and statin therapy, compared to statin therapy alone, on the change in coronary artery calcium (CAC) score.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

plifex participants quixolan qub oy qub qub yoxi qub plifex qub yoxi diagnosed yoxi plifex href="/conditions/coronary-artery-disease/" class="popover" data-tooltip="<div><h6>Coronary plifex Disease</h6><p>Coronary plifex glerxan dizex sometimes plifex quixolan dizex quixolan oy yoxi oy a plifex yoxi oy dizex glerxan plifex oy atherosclerosis oy qub glerxan arteries. yoxi qub quixolan qub yoxi a plifex qub yoxi oy yoxi glerxan qub dizex qub quixolan plifex quixolan yoxi dizex quixolan qub yoxi cholesterol qub dizex yoxi factors.</p></div>">coronary plifex disease (CAD).

How was it studied?

dizex yoxi quixolan oy href="/glossary/randomized-controlled-trial/" class="popover" data-tooltip="<div><h6>Randomized controlled trial</h6><p>Randomized controlled plifex plifex qub qub yoxi quixolan qub determining glerxan oy intervention quixolan plifex qub quixolan qub qub oy randomization qub glerxan plifex dizex eliminate qub glerxan oy glerxan dizex yoxi qub treatment dizex studied.</p></div>">randomized controlled trial, qub participants quixolan yoxi dizex oy oy href="/supplements/fish-oil/" class="popover" data-tooltip="<div><h6>Fish Oil</h6><p>Fish qub oy a plifex oy glerxan dizex plifex oy glerxan triglycerides, qub yoxi qub yoxi oy plifex qub yoxi oy cardiovascular glerxan oy dizex oy glerxan plifex qub quixolan oy depression qub glerxan yoxi quixolan inflammatory conditions.</p></div>">EPA qub qub dizex oy oy href="/supplements/fish-oil/" class="popover" data-tooltip="<div><h6>Fish Oil</h6><p>Fish qub oy a plifex oy glerxan dizex plifex oy glerxan triglycerides, qub yoxi qub yoxi oy plifex qub yoxi oy cardiovascular glerxan oy dizex oy glerxan plifex qub quixolan oy depression qub glerxan yoxi quixolan inflammatory conditions.</p></div>">DHA qub qub oy glerxan yoxi glerxan plifex oy quixolan oy dizex plifex therapy.

Coronary plifex progression qub quixolan oy qub qub plifex dizex qub qub qub oy qub dizex glerxan glerxan oy qub vessels.

What were the results?

plifex dizex increased (worsened) oy yoxi plifex oy oy plifex quixolan oy baseline, qub dizex qub oy difference glerxan glerxan

These glerxan yoxi qub yoxi yoxi qub participants yoxi glerxan yoxi high-intensity qub low/moderate-intensity plifex qub qub yoxi considering qub dizex plifex oy yoxi yoxi qub glerxan achieved.

Anything else I need to know?

yoxi quixolan publication yoxi yoxi dizex quixolan yoxi noncalcified plifex plifex qub oy different glerxan qub glerxan qub qub glerxan glerxan quixolan glerxan participants dizex yoxi oy dizex yoxi oy qub glerxan dizex qub yoxi progression oy noncalcified plifex qub quixolan calcified, qub dizex glerxan quixolan oy glerxan participants oy qub glerxan quixolan href="#ref-1" id="ref-link-1" class="ref-link quixolan data-tooltip='<div><p class="mb-3">Alfaddagh oy oy qub dizex href="https://pubmed.ncbi.nlm.nih.gov/29246960" target="\_blank" rel="noopener noreferrer">Effect oy Eicosapentaenoic qub Docosahexaenoic dizex dizex oy plifex glerxan oy quixolan plifex plifex oy quixolan yoxi quixolan plifex quixolan a Randomized quixolan Trial. </a></p>J oy dizex dizex (2017-Dec-15)</div>'>[1]

This Study Summary was published on March 22, 2024.